drugset / Trial / NCT00709046

High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment

NCT00709046

RandomizedParallel-groupSingle-blindTreatment

Summary

The study was designed to evaluate the efficacy an adjuvant use of standard dose or high dose of proton pump inhibitor after combined endoscopic hemostasis therapy.

Timeline

Start
2008-01
Primary completion
2010-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Pantoprazole Other / unclassified 8 mg Intravenous
Subject Pantoprazole Other / unclassified 40 mg Intravenous